市場調查報告書

氣動霧化器市場增長,趨勢,預測(2020-2025)

Pneumatic Nebulizer Market - Growth, Trends, and Forecasts (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 946303
出版日期 內容資訊 英文 117 Pages
商品交期: 2-3個工作天內
價格
氣動霧化器市場增長,趨勢,預測(2020-2025) Pneumatic Nebulizer Market - Growth, Trends, and Forecasts (2020 - 2025)
出版日期: 2020年06月01日內容資訊: 英文 117 Pages
簡介

預計在預測期內,氣動霧化器市場的複合年增長率為5.3%。預計呼吸道疾病病例的增加和人口的老齡化將推動市場增長。根據《全球疾病負擔研究》,約有2.51億人患有慢性阻塞性肺疾病(COPD),而COPD死亡的90%以上發生在中低收入國家。因此,隨著患者對家庭護理設備的引入的增加,有望加速氣動霧化器市場的增長。

該報告調查了氣動霧化器市場,並提供了市場概況以及按便攜性,銷售渠道,地區和進入市場的公司概況的趨勢。

內容

第1章簡介

第2章調查方法

第3章執行摘要

第4章市場動態

  • 市場概況
  • 市場增長因素
    • 呼吸系統疾病負擔增加
    • 對家庭醫療設備的需求增加
    • 增加老年人口
  • 市場約束因素
    • 藥物輸送過程中的藥物損失
  • 波特的五力分析

第5章市場細分

  • 通過便攜性
    • 桌面
    • 便攜式
  • 通過銷售渠道
    • 直接購買
    • 在線購買
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他地區

第6章競爭情況

  • 公司簡介
    • Aerogen
    • Heyer Medical AG
    • GE Healthcare
    • Abbvie Inc. (Agilent Technologies)
    • Salter Labs
    • Medline Industries Inc.
    • Briggs Healthcare
    • PARI Pharma
    • Omron Healthcare

第7章市場機會和未來趨勢

目錄
Product Code: 70633

The pneumatic nebulizer market is expected to register a 5.3 % of CAGR over the forecast period. The increasing number of cases of respiratory diseases and increasing geriatric population is expected to drive the market growth. According to the Global Burden of Disease Study, the prevalence of chronic pulmonary respiratory diseases (COPD) was found to be around 251 million and more than 90% of the COPD deaths occure in low- and middle-income countries. Hence, with the rising adoption of homecare devices by the patients it is expected to fuel the pneumatic nebulizer market growth.

Key Market Trends

Portable Pneumatic Nebulizer is Expected to Exhibit a Significant Market Growth Over the Forecast Period

Portable pneumatic nebulizer is expected to show a robust growth owing to the rising prevalence of respiratory diseases such as asthma and COPD and increasing geriatric population. The rising adoption of portable nebulizer due to its convenience and effectiveness is expected to influence positively on the growth. According to the study of Analytica Chimica Acta, 2020, pneumatic nebulizer was used for introducing metallic ionic meta callibrant solutions and nanoparticles. Furthermore, according to the World Health Organization, currently there are approximately 339 million people in the world living with asthma and over 80% of these reside in low- and middle- income countries. Hence, these factors are expected to impact positiviely on the market growth.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to be a dominant region in the Pneumatic Nebulizer market owing to higher prevalence of respiratory diseases and increasing geriatric population. According to the Centre for Disease Control and Prevention, in 2017, prevalence of asthma in male was found to be approximately 6.4% and 9.3% in female in the United States. Moreover, according to the U.S. Department of Health and Human Services, around 33,401 Americans suffered from emphysema in 2018. This is expected to increase the demand for pneumatic nebulizers and thereby propelling the market growth.

Competitive Landscape

Some of the well-known compaies in Pneumatic Nebulizer market inlcude Aerogen, Heyer Medical AG, GE Healthcare, Agilent Technologies, Salter Labs, Medline Industries Inc., Briggs Healthcare, PARI Pharma and Omron Healthcare.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Burden of Respiratory Diseases
    • 4.2.2 Increasing Demand for Home Healthcare Devices
    • 4.2.3 Increasing Geriatric Population
  • 4.3 Market Restraints
    • 4.3.1 Drug Loss during Drug Delivery
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Portability
    • 5.1.1 Tabletop
    • 5.1.2 Portable
  • 5.2 By Sales Channel
    • 5.2.1 Direct Purchase
    • 5.2.2 Online Purchase
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Rest of the World

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Aerogen
    • 6.1.2 Heyer Medical AG
    • 6.1.3 GE Healthcare
    • 6.1.4 Abbvie Inc. (Agilent Technologies)
    • 6.1.5 Salter Labs
    • 6.1.6 Medline Industries Inc.
    • 6.1.7 Briggs Healthcare
    • 6.1.8 PARI Pharma
    • 6.1.9 Omron Healthcare

7 MARKET OPPORTUNITIES AND FUTURE TRENDS